Tris[(R)-lactamide-kappa2O,O']zinc(II) tetrabromozincate.
The title compound, tris[(R)-2-hydroxypropanamide-kappa2O,O']zinc(II) tetrabromozincate, [Zn(C3H7NO2)3][ZnBr4], contains one monomeric six-coordinate zinc complex cation and one tetrahedral [ZnBr4]2- anion. Both Zn(II) atoms lie on threefold axes. Coordination in the cation occurs via the amide and hydroxy O atoms [Zn-O = 2.074 (5) and 2.073 (6) A] and has a distorted octahedral geometry, with cis-O-Zn-O angles in the range 76.2 (2)-109.2 (2) degrees . In the crystal structure, the cations and anions are linked by N-H...Br and O-H...O hydrogen bonds, generating a three-dimensional network.
Bekaert
Alain
A
Université de Paris XI, Faculté des Sciences Pharmaceutiques et Biologiques, Laboratoire de Chimie Thérapeutique BioCIS, UPRES-A 8076 CNRS, 5 rue J. B. Clément, 92296 Châtenay-Malabry Cedex, France.
Lemoine
Pascale
P
Brion
Jean Daniel
JD
Viossat
Bernard
B
D000577:Amides / Q000737:chemistry*; D018360:Crystallography, X-Ray; D006860:Hydrogen Bonding; D008968:Molecular Conformation; D015394:Molecular Structure; D009942:Organometallic Compounds / Q000737:chemistry*; D015032:Zinc / Q000737:chemistry*
D000577:Amides; D009942:Organometallic Compounds; C013083:lactamide; D015032:Zinc